Episode 367: PREMIUM – Two anti-inflammatory treatments at very different costs, and one more
In episode 367, Mike and James talk about the latest cardiovascular medication canakinumab, and a systematic review of corticosteroids for the treatment of a sore throat. And to really make it PREMIUM we throw in a quick discussion about a new study on the T2DM medication exenatide.
Show notes
1) Antiinflammatory therapy with canakinumab for atherosclerotic disease
2) Corticosteroids for treatment of sore throat: systematic review and meta-analysis of randomised trials
BMJ 2017 Sep 20;358:j3887. doi: 10.1136/bmj.j3887
3) Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
Listening to this episode is for premium podcast members only. If you already have a membership, login to your account. If you aren't yet a premium subscriber, sign up today!
